Jones Day's PTAB Litigation Blog, Home page
Claim Construction Clash Leads to Invalidity Reprieve

Claim Construction Clash Leads to Invalidity Reprieve

By Anthony Bautista and Matt Johnson - In XR Communications, LLC v. D-Link Systems, Inc. Et. Al., a judge in the Central District of California found that certain asserted claims claiming to wireless communication technology were barred by the doctrine of collateral...

read more
Fintiv Discretionary Denials Remain In Play

Fintiv Discretionary Denials Remain In Play

By Hannah Mehrle and Matt Johnson - F5 Networks, Inc. (“Petitioner”) filed a Petition requesting an IPR.  WSOU Investments, LLC d/b/a/ Brazos Licensing and Development (“Patent Owner”) filed a Preliminary Response.  Here, the PTAB exercised its discretion under 35...

read more
Third Post-Arthrex Grant of Director Review Issued

Third Post-Arthrex Grant of Director Review Issued

By Jareli Reynoso Gutierrez and Matt Johnson - On March 3, 2022, Andrew Hirshfeld, the Commissioner for Patents and acting Director of the USPTO, issued the third post-Arthrex grant of Director Review for two separate Final Written Decisions issued by the PTAB based...

read more
Section 316(a)(11) Time Limits Do Not Apply Beyond First FWD

Section 316(a)(11) Time Limits Do Not Apply Beyond First FWD

By Haytham Soliman and Matt Johnson - In Laboratoire Francais du Fractionnement et des Biotechnologies S.A. v. Novo Nordisk Healthcare AG, the Patent Trial and Appeal Board (PTAB) denied the Petitioner’s motion to terminate the inter partes review (IPR) and to vacate...

read more

About this blog

Archives